Insights into FDA's controversial decision to approve a new Alzheimer's treatment drug
Episode Ep 28 13 min 28s

Insights into FDA's controversial decision to approve a new Alzheimer's treatment drug

Listen to Health Affairs' Rob Lott and Leslie Erdelack discuss the FDA's controversial decision to approve Aduhelm (aducanumab) to treat patients with Alzheimer's disease.

You May Also Like

Community discussion